Drugs

NIH begins a Phase 3 clinical trial to gather data on tecovirimat

Side effects of PI3Kδ immunotherapy could be mitigated by changing drug dosing

Taking metformin just prior to conception linked to higher risk of birth defects

Recent discovery helps scientists understand why some tumors lack immune cell infiltration and are therefore unresponsive to newer PD-1 targeted therapies 

Duration depends on the biological matrix

Few novel drugs have been developed to treat neglected diseases in recent decades

As drug test adulteration becomes more sophisticated, so do detection methods

New treatment option for patients who no longer respond to hormone therapy

Large NIH-funded study examined outcomes in the United States and Australia